Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 23, 2022

Accession no.
0001209191-22-062645
Filed
Dec 23, 2022
Trade date
Nov 1-30, 2022
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.54K. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2022Common StockPPurchaseAcquired+31$2.53+$78.4325,006Direct
Nov 2, 2022Common StockPPurchaseAcquired+31$2.54+$78.7425,037Direct
Nov 3, 2022Common StockPPurchaseAcquired+31$2.44+$75.6425,068Direct
Nov 4, 2022Common StockPPurchaseAcquired+31$2.42+$75.0225,099Direct
Nov 7, 2022Common StockPPurchaseAcquired+31$2.45+$75.9525,130Direct
Nov 8, 2022Common StockPPurchaseAcquired+31$2.42+$75.0225,161Direct
Nov 9, 2022Common StockPPurchaseAcquired+31$2.37+$73.4725,192Direct
Nov 10, 2022Common StockPPurchaseAcquired+31$2.37+$73.4725,223Direct
Nov 11, 2022Common StockPPurchaseAcquired+31$2.32+$71.9225,254Direct
Nov 14, 2022Common StockPPurchaseAcquired+31$2.32+$71.9225,285Direct
Nov 15, 2022Common StockPPurchaseAcquired+31$2.35+$72.8525,316Direct
Nov 16, 2022Common StockPPurchaseAcquired+31$2.31+$71.6125,347Direct
Nov 17, 2022Common StockPPurchaseAcquired+31$2.29+$70.9925,378Direct
Nov 18, 2022Common StockPPurchaseAcquired+31$2.27+$70.3725,409Direct
Nov 21, 2022Common StockPPurchaseAcquired+31$2.38+$73.7825,440Direct
Nov 22, 2022Common StockPPurchaseAcquired+31$2.37+$73.4725,471Direct
Nov 23, 2022Common StockPPurchaseAcquired+31$2.29+$70.9925,502Direct
Nov 25, 2022Common StockPPurchaseAcquired+31$2.31+$71.6125,533Direct
Nov 28, 2022Common StockPPurchaseAcquired+31$2.37+$73.4725,564Direct
Nov 29, 2022Common StockPPurchaseAcquired+31$2.34+$72.5425,595Direct
Nov 30, 2022Common StockPPurchaseAcquired+31$2.32+$71.9225,626Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)